Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

2 min read

Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)

May 20, 2020 at 11:00 PM

Press Release

Read press release

2 min read

AGC Biologics to Participate in First-Ever BIO Digital Conference

May 13, 2020 at 6:16 PM

Press Release

Read press release

2 min read

AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment

May 5, 2020 at 1:47 PM

Press Release

Read press release

AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab

April 29, 2020 at 3:49 PM

Press Release

Read press release

2 min read

AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine

April 24, 2020 at 5:00 AM

Press Release

Read press release

AGC Biologics in the news for our work toward COVID-19 treatment

April 6, 2020 at 7:37 AM

Press Release

Read press release

2 min read

AGC Inc. Decides to Launch Voluntary Tender Offer for Shares of Molmed

March 17, 2020 at 9:54 AM

Press Release

Read press release

AGC Biologics Plasmid Production

March 16, 2020 at 1:58 PM

Press Release

Read press release

2 min read

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

February 7, 2020 at 1:38 PM

Press Release

Read press release

2 min read

AGC Biologics Expands Plasmid DNA Offering

December 11, 2019 at 1:42 PM

Press Release

Read press release

Prev 7 8 9 10 11 Next

Our Company

Locations

Policies

Offerings

Services

Specialized Platforms & Programs

News & Blogs

Resources

Fact Sheet Quick Links

Join Us

What Drives Us

Meet Our Teams

Press Releases

Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)

AGC Biologics to Participate in First-Ever BIO Digital Conference

AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment

AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab

AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine

AGC Biologics in the news for our work toward COVID-19 treatment

AGC Inc. Decides to Launch Voluntary Tender Offer for Shares of Molmed

AGC Biologics Plasmid Production

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

AGC Biologics Expands Plasmid DNA Offering

Our Mission

Links

News

Pandorum Partners with AGC Biologics to Support Clinical Manufacturing of Exosome-Based Kuragenx, a Treatment of Ulcerative Corneal Blindness

Events

Advanced Therapies Week, January 20-23